📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: JenaValve

1.1 - Company Overview

JenaValve Logo

JenaValve

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of transcatheter heart valve solutions, including the Trilogy Heart Valve System for TAVR to treat severe aortic regurgitation or stenosis, featuring a self-expanding nitinol frame and locator technology for precise placement. Offers the Trilogy Valve for secure anchoring without calcium, a Delivery System for precise deployment, and an 85cm pre-shaped Introducer Sheath for safe vascular access.

Products and services

  • Trilogy Delivery System: A delivery mechanism engineered for precise deployment of the Trilogy Valve, featuring integrated rotation and catheter deflection for alignment
  • Trilogy Heart Valve System: A TAVR system for severe aortic regurgitation or stenosis, with a self-expanding nitinol frame and locator technology enabling precise placement
  • Trilogy Valve: A transcatheter aortic valve with locator technology for secure anchoring without calcium, suitable for severe aortic regurgitation

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to JenaValve

Renovacor Logo

Renovacor

HQ: United States Website
  • Description: Provider of preclinical-stage biopharmaceutical development of transformative gene therapy-based treatments for cardiovascular disease, featuring a lead recombinant adeno-associated virus (AAV) gene therapy program for patients with dilated cardiomyopathy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Renovacor company profile →
Bellerophon Therapeutics Logo

Bellerophon Therapeutics

HQ: United States Website
  • Description: Provider of innovative products that combine novel drugs and devices for the treatment of cardiopulmonary diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bellerophon Therapeutics company profile →
Cardiac Dimensions Logo

Cardiac Dimensions

HQ: United States Website
  • Description: Provider of tools and techniques for the treatment of heart failure and related conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cardiac Dimensions company profile →
CinCor Pharma Logo

CinCor Pharma

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on cardiovascular, metabolic, and kidney diseases, advancing promising clinical candidates toward marketing approval, including CIN-107, a novel aldosterone synthase inhibitor.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CinCor Pharma company profile →
Silk Road Medical Logo

Silk Road Medical

HQ: United States Website
  • Description: Provider of less-invasive medical devices and solutions for treating vascular diseases, specializing in carotid artery disease through proprietary trans-carotid therapies. Offers the TransCarotid Artery Revascularization (TCAR) procedure with reverse flow neuroprotection and a system that redirects blood away from the brain to capture debris before returning it to a leg vessel.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Silk Road Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for JenaValve

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to JenaValve

2.2 - Growth funds investing in similar companies to JenaValve

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for JenaValve

4.2 - Public trading comparable groups for JenaValve

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to JenaValve

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About JenaValve

What does JenaValve do?

JenaValve is a provider of transcatheter heart valve solutions, including the Trilogy Heart Valve System for TAVR to treat severe aortic regurgitation or stenosis, featuring a self-expanding nitinol frame and locator technology for precise placement. Offers the Trilogy Valve for secure anchoring without calcium, a Delivery System for precise deployment, and an 85cm pre-shaped Introducer Sheath for safe vascular access.

Who are JenaValve's competitors?

JenaValve's competitors and similar companies include Renovacor, Bellerophon Therapeutics, Cardiac Dimensions, CinCor Pharma, and Silk Road Medical.

Where is JenaValve headquartered?

JenaValve is headquartered in United States.

How many employees does JenaValve have?

JenaValve has 1,000 employees 🔒.

When was JenaValve founded?

JenaValve was founded in 2010 🔒.

What sector and industry vertical is JenaValve in?

JenaValve is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for JenaValve

Who are the top strategic acquirers in JenaValve's sector and industry

Top strategic M&A buyers and acquirers in JenaValve's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for JenaValve?

Top strategic M&A buyers groups and sectors for JenaValve include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in JenaValve's sector and industry vertical

Which are the top PE firms investing in JenaValve's sector and industry vertical?

Top PE firms investing in JenaValve's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in JenaValve's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in JenaValve's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in JenaValve's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to JenaValve include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in JenaValve's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for JenaValve?

The key public trading comparables and valuation benchmarks for JenaValve include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for JenaValve for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for JenaValve with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in JenaValve's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for JenaValve with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in JenaValve's' sector and industry vertical?

Access recent funding rounds and capital raises in JenaValve's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for JenaValve